{"nct_id":"NCT06567782","title":"A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2025-02-17","start_date_type":"ACTUAL","primary_completion_date":"2026-07-06","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06-15","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}